z-logo
open-access-imgOpen Access
Reducing Unnecessary Biopsy During Prostate Cancer Screening Using a Four-Kallikrein Panel: An Independent Replication
Author(s) -
Andrew J. Vickers,
Angel M. Cronin,
Monique J. Roobol,
Caroline Savage,
Mari Peltola,
Kim Pettersson,
Peter T. Scardino,
Fritz H. Schröder,
Hans Lilja
Publication year - 2010
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2009.24.1968
Subject(s) - medicine , prostate cancer , biopsy , rectal examination , prostate biopsy , cancer , cohort , prostate , prostate specific antigen , population , oncology , urology , environmental health
We previously reported that a panel of four kallikrein forms in blood-total, free, and intact prostate-specific antigen (PSA) and kallikrein-related peptidase 2 (hK2)-can reduce unnecessary biopsy in previously unscreened men with elevated total PSA. We aimed to replicate our findings in a large, independent, representative, population-based cohort.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom